 SAN DIEGO WASHINGTON--BUSINESS WIRE--- VNDA ClassAction--Shareholder rights law firm Robbins LLP announces that Vanda Pharmaceuticals Inc. NASDAQ: VNDA may face damages caused by a pending securities lawsuit. Vanda Pharmaceuticals Inc. is a biopharmaceutical company that focuses on the development and commercialization of products for the treatment of central nervous system disorders. If you suffered a loss as a result of Vandas misconduct, click here. Shareholder Class Action Alleging Vanda Pharmaceuticals 